equitybuy

BASFY · BASF SE

Trust-weighted public proof page for BASFY. See which authors support it, which ticker theses it belongs to, and how thesis calls have performed.

Opportunity
31 / 100
Current score
0.49
Thesis calls
3
Active decisions
4

Recent proof-backed thesis calls

Public preview of asset-level thesis calls linked to source content, observed prices, and outcomes.

Anecdotal social post claims higher-dose Vitamin K2 (MK-4) plus Vitamin E (mixed tocopherols) improved testosterone/LH dynamics, with commentary that high LH can indicate reduced Leydig-cell sensitivity and oxidative stress/circadian factors. This is not investable as a catalyst by itself, but it loosely reinforces an existing supplement/ingredients demand narrative (fat-soluble vitamins, antioxidant positioning).

Mentioned: Jul 22, 2026, 3:21 PM EDTConviction: 34 / 100
Source: _aestheticprimal_ @aestheticprimal Jul 22 I've witnessed interesting reductions in LH whereas Testosterone shot up fr...

USGS-style overview of germanium: byproduct of zinc processing; demand shifted from early electronics to fiber optics, infrared/night vision, and polymerization catalysts; recent (as of text) consumption > primary production offset by stockpiles and recycling; includes a historical 2000 year-end price ($1,150/kg).

Mentioned: Jul 5, 2026, 7:17 AM EDTConviction: 30 / 100
Source: Germanium Statistics and Information
Private Talksyoutubeopen

Interview-style discussion (no single new headline) about Russia’s fiscal strain (“money running out”), potential VAT (НДС) increases, ongoing/lasting sanctions, the EU debating use of frozen Russian assets, and recession risk. The actionable angle is macro/geopolitics: prolonged sanctions and higher Russia fiscal pressure tend to support defense spending, sustain energy/geopolitical risk premia, and weigh on Europe’s growth-sensitive/energy-intensive sectors. However, the entry itself does not

Mentioned: Oct 23, 2025, 1:11 PM EDTConviction: 44 / 100
Source: "Money is Running Out": New Sanctions, Taxes, and the Budget | Ruben Yenikolopov on Russia, Europ...

Current stance

Recommendationbuy
Authors3
Active decisions4
Latest price$16.10

Investment decisions

BASFY
risk_review

BASFY
research_buy

BASFY
research_buy

BASFY
watch

Unlock full asset monitoring

Create an account to inspect complete asset history, trust-weighted rankings, and persisted evidence across authors, theses, and market events.